NICKOLA BOOKER: Open Payments
NPI 1225088438 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 53 payments from 14 companies in 2025. Trend: 2023 $675 · 2024 $731 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $280 |
| GENZYME CORPORATION | 6 | $119 |
| Ardelyx, Inc. | 5 | $97 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
| Ipsen Biopharmaceuticals, Inc | 3 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $57 |
| PFIZER INC. | 3 | $46 |
| Gilead Sciences, Inc. | 2 | $41 |
| Madrigal Pharmaceuticals | 2 | $39 |
| Janssen Biotech, Inc. | 2 | $31 |
Products named: DUPIXENT, RINVOQ, IBSRELA, CREON, IQIRVO, XIFAXAN, REZDIFFRA, XELJANZ.
Industry payments across GA — which companies pay providers there.
